Development of Pyrazolo[3,4- d ]pyrimidine Kinase Inhibitors as Potential Clinical Candidates for Glioblastoma Multiforme (2020)
Attributed to:
Next Generation Biomaterials Discovery
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1021/acsmedchemlett.9b00530
PubMed Identifier: 32435367
Publication URI: http://europepmc.org/abstract/MED/32435367
Type: Journal Article/Review
Parent Publication: ACS Medicinal Chemistry Letters
Issue: 5
ISSN: 1948-5875